Abstract
Extracellular matrix (ECM) plays important roles in tissue engineering because cellular growth and differentiation, in the two-dimensional cell culture as well as in the three-dimensional space of the developing organism, require ECM with which the cells can interact. Also, the development of new synthetic ECMs is very important because ECMs facilitate the localization and delivery of cells to the specific sites in the body. Therefore, the development of synthetic ECMs to replace the natural ECMs is increasingly essential and promising in tissue engineering. Recombinant genetic engineering method has enabled the synthesis of protein-based polymers with precisely controlled functionalities for the development of new synthetic ECMs. In this review, the design and construction of structure-based recombinant fusion proteins such as elastin-like polymers (ELPs) and silk-like polymers (SLPs), cell-bound growth factor-based recombinant fusion proteins such as basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF), hybrid system composed of recombinant protein and synthetic polymer, and E-cadherin-based fusion protein by recombinant genetic engineering were explained for application of the synthetic ECMs. Modulation of mechanical properties, stimuli-sensitivity, biodegradation and cell recognition can be achieved through precise control of sequence, length, hydrophobicity and cell binding domain by recombinant genetic engineering.
Similar content being viewed by others
References
Abatangelo, G., P. Brun, M. Radice, R. Cortivo, and M. K. H. Auth. Tissue engineering. In: Integrated Biomaterials Science, edited by R. Barmucci. New York: Kluwer Academic, 2001, p. 885.
Altman, G. H., F. Diaz, C. Jakuba, T. Calabro, R. L. Horan, J. Chen, H. Lu, J. Richmond, and D. L. Kaplan. Silk-based biomaterials. Biomaterials 24:401–416, 2003.
Andrades, J. A., L. T. Wu, F. L. Hall, M. E. Nimmi, and J. Becerra. Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein. Growth Factors 18:261–275, 2001.
Asakura, T., C. Tanaka, M. Yang, J. Yao, and M. Kurokawa. Production and characterization of a silk-like hybrid protein, based on the polyalanine region of Samia cynthia ricini silk fibroin and a cell adhesive region derived from fibronectin. Biomaterials 25:617–624, 2004.
Atala, A., and D. Mooney. Synthetic Biodegradable Polymer Scaffolds. Boston: Birkhauser, 1997.
Bini, E., C. W. Foo, J. Huang, V. Karageorgiou, B. Kitchel, and D. L. Kaplan. RGD-functionalized bioengineered spider dragline silk biomaterial. Biomacromolecules 7:3139–3145, 2006.
Bouhadir, K. H., and D. J. Mooney. In vitro and in vivo models for the reconstruction of intercellular signaling. Ann. NY Acad. Sci. 842:188–194, 1998.
Cappello, J., and K. Park (Eds.). Controlled Drug Delivery: Challenges and Strategies. Washington DC: American Chemical Society, 1997, p. 439.
Chong, B. F., L. M. Blank, R. McLaughlin, and L. K. Nielsen. Microbial hyaluronic acid production. Appl. Microbiol. Biotechnol. 66:341–351, 2005.
Cohen, S. The epidermal growth factor (EGF). Cancer 51:1787–1791, 1983.
Cutler, S. M., and A. J. Garcia. Engineering cell adhesive surfaces that direct integrin alpha5beta1 binding using a recombinant fragment of fibronectin. Biomaterials 24:1759–1770, 2003.
Di Zio, K., and D. A. Tirrell. Mechanical properties of artificial protein matrices engineered for control of cell and tissue behavior. Macromolecules 36:1553–1558, 2003.
Duan, X. J., H. X. Niu, W. S. Tan, and X. Zhang. Mechanism analysis of effect of oxygen on molecular weight of hyaluronic acid produced by Streptococcus zooepidemicus. J. Microbiol. Biotechnol. 19:299–306, 2009.
Ehrbar, M., S. C. Rizzi, R. Hlushchuk, V. Djonov, A. H. Zisch, J. A. Hubbell, F. E. Weber, and M. P. Lutolf. Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. Biomaterials 28:3856–3866, 2007.
Elloumi, I., R. Kobayashi, H. Funabashi, M. Mie, and E. Kobatake. Construction of epidermal growth factor fusion protein with cell adhesive activity. Biomaterials 27:3451–3458, 2006.
Ghandehari, H., and J. Cappello. Genetic engineering of protein-based polymers: potential in controlled drug delivery. Pharm. Res. 15:813–815, 1998.
Ghosh, K., and D. E. Ingber. Micromechanical control of cell and tissue development: implications for tissue engineering. Adv. Drug Deliv. Rev. 59:1306–1318, 2007.
Girotti, A., J. Reguera, J. C. Rodriguez-Cabello, F. J. Arias, M. Alonso, and A. M. Testera. Design and bioproduction of a recombinant multi(bio)functional elastin-like protein polymer containing cell adhesion sequences for tissue engineering purposes. J. Mater. Sci. Mater. Med. 15:479–484, 2004.
Gosline, J. M., M. E. DeMont, and M. W. Denny. The structure and properties of spider silk. Endeavour 10:37–43, 1986.
Griffith, L. G., and G. Naughton. Tissue engineering–current challenges and expanding opportunities. Science 295:1009–1014, 2002.
Haider, M., J. Cappello, H. Ghandehari, and K. W. Leong. In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm. Res. 25:692–699, 2008.
Haider, M., Z. Megeed, and H. Ghandehari. Genetically engineered polymers: status and prospects for controlled release. J. Control Rel. 95:1–26, 2004.
Halstenberg, S., A. Panitch, S. Rizzi, H. Hall, and J. A. Hubbell. Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair. Biomacromolecules 3:710–723, 2002.
Hashi, H., M. Hatai, F. Kimizuka, I. Kato, and Y. Yaoi. Angiogenic activity of a fusion protein of the cell-binding domain of fibronectin and basic fibroblast growth factor. Cell Struc. Func. 19:37–47, 1994.
Hayashi, M., M. Tomita, and K. Yoshizato. Production of EGF-collagen chimeric protein which shows the mitogenic activity. Biochem. Biophys. Acta 1528:187–195, 2001.
Heilshorn, S. C., K. A. Dizio, E. R. Welsh, and D. A. Tirrell. Endothelial cell adhesion to the fibronectin CS5 domain in artificial extracellular matrix proteins. Biomaterials 24:4245–4252, 2003.
Hersel, U., C. Dahmen, and H. Kessler. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24:4385–4415, 2003.
Huang, J., C. Wong, A. George, and D. L. Kaplan. The effect of genetically engineered spider silk-dentin matrix protein 1 chimeric protein on hydroxyapatite nucleation. Biomaterials 28:2358–2367, 2007.
Inoue, C., H. Yamamoto, T. Nakamura, A. Ichihara, and H. Okamoto. Nicotinamide prolongs survival of primary cultured hepatocytes without involving loss of hepatocyte-specific functions. J. Biol. Chem. 264:4747–4750, 1989.
Ishikawa, T., H. Terai, T. Yamamoto, K. Harada, and T. Kitajima. Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues. Artif. Organs 27:147–154, 2003.
Ito, H., A. Steplewski, T. Alabyeva, and A. Gertala. Testing the utility of rationally engineered recombinant collagen-like proteins for applications in tissue engineering. J. Biomed. Mater. Res. A 76:551–560, 2006.
Jang, J. H., J. H. Hwang, and C. P. Chung. Production of recombinant human tenascin-C module containing a cell adhesion recognition motif of RGD. Biotechnol. Lett. 26:1831–1835, 2004.
Jing, P., J. S. Rudra, A. B. Herr, and J. H. Collier. Self-assembling peptide-polymer hydrogels designed from the coiled coil region of fibrin. Biomacromolecules 9:2438–2446, 2008.
Kawase, Y., Y. Ohdate, T. Shimojo, Y. Taguchi, F. Kimizuka, and I. Kato. Construction and characterization of a fusion protein with epidermal growth factor and the cell-binding domain of fibronectin. FEBS Lett. 298:126–128, 1992.
Langer, R., and D. A. Tirrell. Designing materials for biology and medicine. Nature 428:487–492, 2004.
Lazaris, A., S. Arcidiacono, Y. Huang, J. Zhou, F. Duguay, N. Chretien, E. A. Welsh, J. W. Soares, and C. N. Karatzas. Spider silk fibers spun from soluble recombinant silk produced in mammalian cells. Science 295:472–476, 2002.
Lee, J., C. W. Macosko, and D. W. Urry. Elastomeric polypentapeptides cross-linked into matrixes and fibers. Biomacromolecules. 2:170–179, 2001.
Lim, D. W., D. L. Nettles, L. A. Setton, and A. Chilkoti. Rapid cross-linking of elastin-like polypeptides with (hydroxymethyl)phosphines in aqueous solution. Biomacromolecules 8:1463–1470, 2007.
Lim, D. W., D. L. Nettles, L. A. Setton, and A. Chilkoti. In situ cross-linking of elastin-like polypeptide block copolymers for tissue repair. Biomacromolecules 9:222–230, 2008.
Lin, H., B. Chen, W. Sun, W. Zhao, Y. Zhao, and J. Dai. The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds. Biomaterials 27:5708–5714, 2006.
Liu, W., K. Merrett, M. Griffith, P. Fagerholm, S. Dravida, B. Heyne, J. C. Scaiano, M. A. Watsky, N. Shinozatki, N. Lagali, R. Munger, and F. Li. Recombinant human collagen for tissue engineered corneal substitutes. Biomaterials 29:1147–1158, 2008.
Liu, J. C., and D. A. Tirrell. Cell response to RGD density in cross-linked artificial extracellular matrix protein films. Biomacromolecules 9:2984–2988, 2008.
McHale, M. K., L. A. Setton, and A. Chilkoti. Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng. 11:1768–1779, 2005.
Merrett, K., W. Liu, D. Mitra, K. D. Camm, C. R. McLaughlin, Y. Liu, M. A. Watsky, F. Li, M. Griffith, and D. E. Fogg. Synthetic neoglycopolymer-recombinant human collagen hybrids as biomimetic crosslinking agents in corneal tissue engineering. Biomaterials 30:5403–5408, 2009.
Meyer, D. E., and A. Chilkoti. Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 3:357–367, 2002.
Mie, M., Y. Mizushima, and E. Kobatake. Novel extracellular matrix for cell sheet recovery using genetically engineered elastin-like protein. J. Biomed. Mater. Res. Part B: Appl. Biomater. 86B:283–290, 2008.
Nagaoka, M., H. Ise, and T. Akaike. Immobilized E-cadherin model can enhance cell attachment and differentiation of primary hepatocytes but not proliferation. Biotechnol. Lett. 24:1857–1862, 2002.
Nagaoka, M., U. Koshimizu, S. Yuasa, F. Hattori, H. Chen, T. Tanaka, M. Okabe, K. Fukuda, and T. Akaike. E-cadherin-coated plates maintain pluripotent ES cells without colony formation. PLoS One 1:e15, 2006.
Nagapudi, K., W. T. Brinkman, B. S. Thomas, J. O. Park, M. Srinivasarao, E. Wright, V. P. Conticello, and E. L. Chaikof. Viscoelastic and mechanical behavior of recombinant protein elastomers. Biomaterials 26:4695–4706, 2005.
Nagarsekar, A., J. Crissman, M. Crissman, F. Ferrari, J. Cappello, and H. Ghandehari. Genetic engineering of stimuli-sensitive silkelastin-like protein block copolymers. Biomacromolecules 4:602–607, 2003.
Nicol, A., D. C. Gowda, T. M. Parker, and D. W. Urry. Elastomeric polytetrapeptide matrices: hydrophobicity dependence of cell attachment from adhesive (GGIP)n to nonadhesive (GGAP)n even in serum. J. Biomed. Mater. Res. 27:801–810, 1993.
Nicol, A., D. C. Gowda, and D. W. Urry. Cell adhesion and growth on synthetic elastomeric matrices containing Arg-Gly-Asp-Ser-3. J. Biomed. Mater. Res. 26:393–413, 1992.
Niewiadomska, P., D. Godt, and U. Tepass. DE-Cadherin is required for intercellular motility during Drosophila oogenesis. J. Cell Biol. 144:533–547, 1999.
Nishi, N., O. Matsushita, K. Yuube, H. Miyanaka, A. Okabe, and F. Wada. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc. Natl. Acad. Sci. USA 95:7018–7023, 1998.
Nowatzki, P. J., and D. A. Tirrell. Physical properties of artificial extracellular matrix protein films prepared by isocyanate crosslinking. Biomaterials 25:1261–1267, 2004.
Ogiwara, K., M. Nagaoka, C. S. Cho, and T. Akaike. Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc. Biotechnol. Lett. 27:1633–1637, 2005.
Ogiwara, K., M. Nagaoka, C. S. Cho, and T. Akaike. Effect of photo-immobilization of epidermal growth factor on the cellular behaviors. Biochem. Biophys. Res. Commun. 345:255–259, 2006.
Putnam, A. J., and D. J. Mooney. Tissue engineering using synthetic extracellular matrices. Nat. Med. 2:824–826, 1996.
Rapraeger, A. C., A. Krufka, and B. B. Olwin. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252:1705–1708, 1991.
Rizzi, S. C., M. Ehrbar, S. Halstenber, G. P. Raeber, H. G. Schmoeke, H. Hagenmiiller, R. Muller, F. E. Weber, and J. A. Hubbell. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 7:3019–3029, 2006.
Rizzi, S. C., and J. A. Hubbell. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: development and physicochemical characteristics. Biomacromolecules 6:1226–1238, 2005.
Rosso, F., A. Giordano, M. Barbarisi, and A. Barbarisi. From cell-ECM interactions to tissue engineering. J. Cell Physiol. 199:174–180, 2004.
Rosso, F., G. Marino, A. Giordando, M. Barbarishi, D. Parmeggiani, and A. Barbarishi. Smart materials as scaffolds for tissue engineering. J. Cell Physiol. 203:465–470, 2005.
Sandberg, L. B., J. G. Leslie, C. T. Leach, V. L. Alvarez, A. R. Torres, and D. W. Smith. Elastin covalent structure as determined by solid phase amino acid sequencing. Pathol. Biol. 33:266–274, 1985.
Sheng, Z., S. B. Chang, and W. J. Chirico. Expression and purification of a biologically active basic fibroblast growth factor fusion protein. Protein Expr. Purif. 27:267–271, 2003.
Shin, H., S. Jo, and A. G. Mikos. Biomimetic materials for tissue engineering. Biomaterials 24:4353–4364, 2003.
Shiroyanagi, Y., M. Yamato, Y. Yamazaki, H. Toma, and T. Okano. Transplantable urothelial cell sheets harvested noninvasively from temperature-responsive culture surfaces by reducing temperature. Tissue Eng. 9:1005–1012, 2003.
Silva, G. A., C. Czeisler, K. L. Niece, E. Beniash, D. A. Harrington, J. A. Kessler, and S. I. Stupp. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303:1352–1355, 2004.
Squires, C. H., J. Childs, S. P. Eisenberg, P. J. Polverini, and A. Sommer. Production and characterization of human basic fibroblast growth factor from Escherichia coli. J. Biol. Chem. 263:16297–16302, 1988.
Sugahara, K., and H. Kitagawa. Heparin and heparan sulfate biosynthesis. IUBMB Life 54:163–175, 2002.
Sun, W., H. Lin, B. Chen, W. Zhao, Y. Zhao, and J. Dai. Promotion of peripheral nerve growth by collagen scaffolds loaded with collagen-targeting human nerve growth factor-beta. J. Biomed. Mater. Res. 83:1054–1061, 2007.
Tabata, Y., and Y. Ikada. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20:2169–2175, 1999.
Takeichi, M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 7:619–627, 1995.
Tomita, M., H. Munetsuna, T. Sato, T. Adachi, R. Hino, M. Hayashi, K. Shimizu, N. Nakamura, T. Tamura, and K. Yoshzato. Transgenic silkworms produce recombinant human type III procollagen in cocoons. Nat. Biotechnol. 21:52–56, 2003.
Trabbic-Carlson, K., L. A. Setton, and A. Chilkoti. Swelling and mechanical behaviors of chemically cross-linked hydrogels of elastin-like polypeptides. Biomacromolecules 4:572–580, 2003.
Urry, D. W. Molecular machines: How motion and other functions of living organisms can result from reversible chemical changes. Angew. Chem. Int. Ed. Eng. 32:819–841, 1993.
Urry, D. W. Physical chemistry of biological free energy transduction as demonstrated by elastic protein-based polymers. J. Phys. Chem. B 101:11007–11028, 1997.
Urry, D. W. Elastic molecular machines in metabolism and soft-tissue restoration. Trends Biotechnol. 17:249–257, 1999.
Urry, D. W., T. M. Parker, M. C. Reid, and D. C. Gowda. Biocompatibility of the bioelastic materials, poly(GVGVP) and its irradiation cross-linked matrix: summary of generic biological test results. J. Bioact. Compat. Polym. 6:263–282, 1991.
Urry, D. W., A. Pattanaik, J. Xu, T. C. Woods, D. T. McPherson, and T. M. Parker. Elastic protein-based polymers in soft tissue augmentation and generation. J. Biomater. Sci. Polym. Ed. 9:1015–1048, 1998.
Wong, P., C. Foo, and D. L. Kaplan. Genetic engineering of fibrous proteins: spider dragline silk and collagen. Adv. Drug Deliv. Rev. 54:1131–1143, 2002.
Wu, S. C., J. R. Chiang, and C. W. Lin. Novel cell adhesive glycosaminoglycan-binding proteins of Japanese encephalitis virus. Biomacromolecules 5:2160–2164, 2004.
Wu, S. C., J. C. Yu, S. H. Hsu, and D. C. Chen. Artificial extracellular matrix proteins contain heparin-binding and RGD-containing domains to improve osteoblast-like cell attachment and growth. J. Biomed. Mater. Res. A 79:557–565, 2006.
Yang, C., P. J. Hillas, J. A. Baez, M. Nokelainen, J. Balan, J. Tang, R. Spiro, and J. W. Polarek. The application of recombinant human collagen in tissue engineering. BioDrugs 18:103–119, 2004.
Yu, H., and G. Stephanopoulos. Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid. Metab. Eng. 10:24–32, 2008.
Yu, H., K. Tyo, H. Alper, D. Klein-Marcuschamer, and G. Stephanopoulas. A high-throughput screen for hyaluronic acid accumulation in recombinant Escherichia coli transformed by libraries of engineered sigma factors. Biotechnol. Bioeng. 101:788–796, 2008.
Zhao, W., B. Chen, X. Li, H. Lin, W. Sun, Y. Zhao, B. Wang, Y. Zhao, Z. Han, and J. Dai. Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors. J. Biomed. Mater. Res. A 82:630–636, 2007.
Zisch, A. H., M. P. Lutolf, M. Ehrbar, G. P. Raeber, S. C. Rizzi, N. Davies, H. Schmokel, D. Bezuidenhout, V. Djonov, P. Zilla, and J. A. Hubbell. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J. 17:2260–2262, 2003.
Acknowledgment
This work was supported by the funds provided by Korea Research Foundation (KRF) (E00244).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Associate Editor Julia E. Babensee oversaw the review of this article.
Rights and permissions
About this article
Cite this article
Nagaoka, M., Jiang, HL., Hoshiba, T. et al. Application of Recombinant Fusion Proteins for Tissue Engineering. Ann Biomed Eng 38, 683–693 (2010). https://doi.org/10.1007/s10439-010-9935-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-010-9935-3